ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Vincerx Inc

Vincerx Inc (VINC)

0.2071
0.0003
(0.15%)
Closed December 21 4:00PM
0.1966
-0.0105
(-5.07%)
After Hours: 7:56PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.1966
Bid
0.185
Ask
0.2309
Volume
724,858
0.18 Day's Range 0.215
0.183 52 Week Range 9.3722
Market Cap
Previous Close
0.2068
Open
0.185
Last Trade Time
Financial Volume
$ 142,149
VWAP
0.196105
Average Volume (3m)
683,660
Shares Outstanding
33,555,903
Dividend Yield
-
PE Ratio
-15.88
Earnings Per Share (EPS)
-1.2
Revenue
-
Net Profit
-40.16M

About Vincerx Inc

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, u... Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform. Show more

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Website
Headquarters
Wilmington, Delaware, USA
Founded
2021
Vincerx Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VINC. The last closing price for Vincerx was $0.21. Over the last year, Vincerx shares have traded in a share price range of $ 0.183 to $ 9.3722.

Vincerx currently has 33,555,903 shares outstanding. The market capitalization of Vincerx is $6.94 million. Vincerx has a price to earnings ratio (PE ratio) of -15.88.

VINC Latest News

Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943

PALO ALTO, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...

Vincerx Pharma Reports Third Quarter 2024 Financial Results

Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC); additional data expected by early 2025 Completed Phase 1...

Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates

VIP943 demonstrates promising safety and tolerability and achieves two complete responses to date in Phase 1 dose-escalation study, reinforcing the program’s potential and validating the VersAptxβ„’...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.01166.270270270270.1850.220.1835332240.20132979CS
4-0.055136-21.90231035690.2517360.2965750.1835923400.22188498CS
12-0.5034-71.91428571430.70.75990.1836836600.38279063CS
26-0.4161-67.91251836140.61270.85860.1834130150.4588237CS
52-0.4434-69.281250.649.37220.1836505501.8011349CS
156-9.4034-97.95208333339.610.590.1832994831.85238946CS
260-19.9234-99.022862823120.1226.750.1832529943.37531317CS

VINC - Frequently Asked Questions (FAQ)

What is the current Vincerx share price?
The current share price of Vincerx is $ 0.1966
How many Vincerx shares are in issue?
Vincerx has 33,555,903 shares in issue
What is the market cap of Vincerx?
The market capitalisation of Vincerx is USD 6.94M
What is the 1 year trading range for Vincerx share price?
Vincerx has traded in the range of $ 0.183 to $ 9.3722 during the past year
What is the PE ratio of Vincerx?
The price to earnings ratio of Vincerx is -15.88
What is the reporting currency for Vincerx?
Vincerx reports financial results in USD
What is the latest annual profit for Vincerx?
The latest annual profit of Vincerx is USD -40.16M
What is the registered address of Vincerx?
The registered address for Vincerx is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Vincerx website address?
The website address for Vincerx is vincerx.com
Which industry sector does Vincerx operate in?
Vincerx operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
$ 80.55
(8.54%)
281.23M

VINC Discussion

View Posts
georgie18 georgie18 2 weeks ago
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
πŸ‘οΈ0
georgie18 georgie18 3 weeks ago
VINC...2954...🥳...Trying to Reverse here to the Upside...
πŸ‘οΈ0
tw0122 tw0122 2 months ago
VINC .84 + 20% …05:05 PM EDT, 10/07/2024 (MT Newswires) -- Vincerx Pharma (VINC) said its VIP943 leukemia drug showed "promising safety and tolerability," achieving two complete responses to date in a phase 1 dose-escalation study

The VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.

Another data update is expected by the end of the year, the company said.

In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to "champion its future development" in order to focus on VIP943.

Vincerx expects a cash runway into early 2025.

Shares of the company jumped 15% in after-hours activity.

Price: 0.8000, Change: +0.10, Percent Change: +
πŸ‘οΈ0
Laster Laster 8 months ago
What a cluster this stock has become.
Unreal actually. $0.60 to $10 back to $0.60 all within 4 months.
Can’t believe they didn’t try to do the financing when it was trading above $5.
πŸ‘οΈ0
RAlbert RAlbert 8 months ago
Tomorrow will be $1.50
πŸ‘οΈ0
RAlbert RAlbert 8 months ago
No news on dilution yet. When will we see a rebound? Seeking money being lost is the painful part of life
πŸ‘οΈ0
RAlbert RAlbert 8 months ago
Blood bath. I should have waited one more day.
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
Somebody knows something you don’t
πŸ‘οΈ0
RAlbert RAlbert 8 months ago
I don’t find the price and volume the capital raise is. Am I missing anything here?
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
Check for SEC filings
πŸ‘οΈ0
RAlbert RAlbert 8 months ago
Is the capital raise 80% discounted to yesterday price? Insane
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
Check for a capital raise which means dilution
πŸ‘οΈ0
RAlbert RAlbert 8 months ago
Wonder why there is a steep fall in price when the results are not negative.
πŸ‘οΈ0
RAlbert RAlbert 8 months ago
Wonder why there is a steep fall in price when the results are not negative.
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
VINC 10Q due 4/3
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
VINC 10Q due 3/25
Next day settlement 5/28 per SEC mandate
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
VINC new 52.week hi
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
VINC new 52 week high
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
VINC in the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
πŸ‘οΈ0
Tom turtles Tom turtles 10 months ago
Very nice surprise...🆙⬆️
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
VINC new 52 week high
πŸ‘οΈ0
glenn1919 glenn1919 10 months ago
VINC..................................https://stockcharts.com/h-sc/ui?s=VINC&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Awl416 Awl416 10 months ago
160k wall getting gobbled up
πŸ‘οΈ0
Awl416 Awl416 10 months ago
Another leg. Damn
πŸ‘οΈ0
Awl416 Awl416 10 months ago
Who’s poking it?
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
VINC under $2
πŸ‘οΈ0
make it happen make it happen 11 months ago
It's deficient. Failed to meet NASDAQs listing requirements. I'm expecting a reverse split in the future.
πŸ‘οΈ0
alchemytrader alchemytrader 11 months ago
moving...
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
VINC under $2
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock